Checkpoint Therapeutics Inc (CKPT)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current CKPT market cap is 75.91M. The company's latest EPS is USD -1.4070 and P/E is -1.49.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 35k | 31k | 31k | 6k | 0 |
| Operating Income | -18.08M | -16.2M | -7.7M | -10.17M | -10.95M |
| Net Income | -10.47M | -16.52M | -5.72M | -19.13M | -10.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.71M | 1.07M | 268k | 192k | 103k |
| Operating Income | -24.85M | -23.2M | -56.72M | -58.33M | -52.15M |
| Net Income | -24.71M | -23.08M | -56.67M | -62.62M | -51.85M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 5.9M | 8.34M | 2.22M | 5.38M | 11.98M |
| Total Liabilities | 28.08M | 31.61M | 21.26M | 18.43M | 22.23M |
| Total Equity | -22.18M | -23.27M | -19.04M | -13.05M | -10.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 26.97M | 42.6M | 55.73M | 13.29M | 5.38M |
| Total Liabilities | 8.12M | 7.22M | 25.98M | 32.77M | 18.43M |
| Total Equity | 18.85M | 35.38M | 29.75M | -19.48M | -13.05M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -14.03M | -26.01M | -40.76M | -47.59M | -6.47M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 6.81M | 21.36M | 30.46M | 40.45M | 12.79M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -21.37M | -16.55M | -26.31M | -57.55M | -47.59M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 25.46M | 31.25M | 40.27M | 14.89M | 40.45M |
| Market Cap | 75.91M |
| Price to Earnings Ratio | -1.49 |
| Price to Sales Ratio | 750 |
| Price to Cash Ratio | 15.71 |
| Price to Book Ratio | -5.93 |
| Dividend Yield | - |
| Shares Outstanding | 36.85M |
| Average Volume (1 week) | 382.53k |
| Average Volume (1 Month) | 379.81k |
| 52 Week Change | -15.92% |
| 52 Week High | 3.62 |
| 52 Week Low | 1.30 |
| Spread (Intraday) | 0.02 (0.97%) |
| Company Name | Checkpoint Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.checkpointtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
